Perkins Capital Management’s Boston Scientific BSX Stock Holding History

Perkins Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$547K	Sell	16,749 -5,434	-24%	-$212K	0.66%	51
2019 Q4	$1M	Sell	22,183 -7,333	-25%	-$307K	0.9%	39
2019 Q3	$1.2M	Sell	29,516 -334	-1%	-$14.2K	1.03%	34
2019 Q2	$1.28M	Hold	29,850	–	–	0.9%	33
2019 Q1	$1.15M	Sell	29,850 -5,000	-14%	-$191K	0.75%	42
2018 Q4	$1.23M	Sell	34,850 -50	-0.1%	-$1.81K	0.96%	29
2018 Q3	$1.34M	Hold	34,900	–	–	0.81%	41
2018 Q2	$1.14M	Buy	+34,900	New	+$1.05M	0.82%	41
2017 Q4	–	Sell	-7,000	Closed	-$204K	–	113
2017 Q3	$204K	Buy	+7,000	New	+$193K	0.21%	84
2016 Q3	–	Sell	-50,650	Closed	-$1.18M	–	113
2016 Q2	$1.18M	Buy	+50,650	New	+$1.1M	1.36%	22

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Perkins Capital Management's BSX Position: Q1 2020 in Review

Perkins Capital Management reduced its Boston Scientific (BSX) stake by 24% in Q1 2020, selling an estimated $212K and leaving 16,749 shares worth $547K. The position accounts for 0.66% of the portfolio, ranked #51.

Perkins Capital Management first reported a position in BSX in Q2 2016 and has held it in 10 quarters since. The position peaked at $1.34M in Q3 2018. 801 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

Perkins Capital Management held 16,749 shares of Boston Scientific worth $547K as of Q1 2020.
Perkins Capital Management sold 5,434 Boston Scientific shares in Q1 2020, an estimated $212K.
Boston Scientific made up 0.66% of Perkins Capital Management's portfolio in Q1 2020, its #51 holding.
Perkins Capital Management first reported a position in Boston Scientific in Q2 2016 and has held it in 10 quarters since.
Perkins Capital Management's Boston Scientific position peaked at $1.34M in Q3 2018.
801 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Perkins Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.